The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response
Open accessAbstract
C-reactive protein (CRP) is a serum protein that is massively induced as part of the innate immune response to infection and tissue injury. As CRP has been detected in damaged tissues and is known to activate complement, we assessed whether apoptotic lymphocytes bound CRP and determined the effect of binding on innate immunity. CRP bound to apoptotic cells in a Ca2+-dependent manner and augmented the classical pathway of complement activation but protected the cells from assembly of the terminal complement components. Furthermore, CRP enhanced opsonization and phagocytosis of apoptotic cells by macrophages associated with the expression of the antiinflammatory cytokine transforming growth factor β. The antiinflammatory effects of CRP required C1q and factor H and were not effective once cells had become necrotic. These observations demonstrate that CRP and the classical complement components act in concert to promote noninflammatory clearance of apoptotic cells and may help to explain how deficiencies of the classical pathway and certain pentraxins lead to impaired handling of apoptotic cells and increased necrosis with the likelihood of immune response to self.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vermes, I., Haanen, C., Steffens-Nakken, H., & Reutellingsperger, C. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00072-i · Cited by 5,410
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166 · cited 9×
“It has been shown that phagocytosis of apoptotic or necrotic cells leads to the synthesis of anti- or proinflammatory cytokines such as TGFb or TNFa , respectively (33, 34).”
BackgroundResultInfluentialBaumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A., van Schie, R. C., LaFace, D. M., & Green, D. R. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1545 · Cited by 2,824
Immunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Casciola-Rosen, L. A., Anhalt, G., & Rosen, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,717
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,602
Serological reactions in pneumonia with a non-protein somatic fraction of Pneumococcus
Tillett, W. S., & Francis, T. (1930) · Journal of Experimental Medicine · doi:10.1084/jem.52.4.561 · Cited by 1,482
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434
The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells
Steinman, R. M., Turley, S., Mellman, I., & Inaba, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.411 · Cited by 1,172
Steel, D. M., & Whitehead, A. S. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90138-4 · Cited by 1,025
Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases
Caron, E., & Hall, A. (1998) · Science · doi:10.1126/science.282.5394.1717 · Cited by 1,019
Repeat-induced gene silencing in mammals
Garrick, D., Fiering, S., Martin, D. I. K., & Whitelaw, E. (1998) · Nature Genetics · doi:10.1038/ng0198-56 · Cited by 887
The physiological structure of human C-reactive protein and its complex with phosphocholine
Thompson, D., Pepys, M. B., & Wood, S. P. (1999) · Structure · doi:10.1016/s0969-2126(99)80023-9 · Cited by 818 · cited 1×
“Furthermore, the striking degree of sequence homology between species and lack of polymorphisms within species (39) suggests that the selection pressures to maintain homeostatic function are more important than pressures from infectious organisms.”
BackgroundComplement-dependent Clearance of Apoptotic Cells by Human Macrophages
Mevorach, D., Mascarenhas, J. O., Gershov, D., & Elkon, K. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2313 · Cited by 700
Self-citationVerhoven, B., Schlegel, R. A., & Williamson, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1597 · Cited by 666
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Kaplan, M. H., & Volanakis, J. E. (1974) · PubMed · Cited by 563
Gurd, A., & Wilson, R. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91669-8 · Cited by 526
Griselli, M., Herbert, J., Hutchinson, W. L., Taylor, K. M., Sohail, M., Krausz, T., & Pepys, M. B. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1733 · Cited by 508
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
Bickerstaff, M. C. M., Botto, M., Hutchinson, W. L., Herbert, J., Tennent, G. A., Bybee, A., Mitchell, D. A., Cook, H. T., Butler, P. J. G., Walport, M. J., et al. (1999) · Nature Medicine · doi:10.1038/9544 · Cited by 489
Wright, S. D., & Silverstein, S. C. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.6.2016 · Cited by 487
Interaction of C-Reactive Protein Complexes with the Complement System
Kaplan, M. H., & Volanakis, J. E. (1974) · The Journal of Immunology · doi:10.4049/jimmunol.112.6.2135 · Cited by 405
C1q and Systemic Lupus Erythematosus
Walport, M. J., Davies, K. A., & Botto, M. (1998) · Immunobiology · doi:10.1016/s0171-2985(98)80032-6 · Cited by 393
The Major Receptor for C-Reactive Protein on Leukocytes Is Fcγ Receptor II
Bharadwaj, D., Stein, M.-P., Volzer, M., Mold, C., & Clos, T. W. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.4.585 · Cited by 391
Apoptosis in rheumatoid arthritis synovium.
Firestein, G. S., Yeo, M., & Zvaifler, N. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118202 · Cited by 383
Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects
Morgan, B. P. (1989) · Biochemical Journal · doi:10.1042/bj2640001 · Cited by 380
Apoptosis: The importance of being eaten
Ren, Y., & Savill, J. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400407 · Cited by 347
Regulation of complement activation by C-reactive protein
Mold, C., Gewurz, H., & Du Clos, T. W. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00007-7 · Cited by 326
C-reactive protein and the acute phase response
Pepys, M. B. (1982) · Immunology Today · doi:10.1016/0167-5699(82)90052-4 · Cited by 312
Complement deficiency and disease
Morgan, B. P., & Walport, M. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90003-c · Cited by 302
Volanakis, J. E., & Kaplan, M. H. (1974) · PubMed · Cited by 267
INTERACTIONS OF C-REACTIVE PROTEIN WITH THE COMPLEMENT SYSTEM
Siegel, J., Rent, R., & Gewurz, H. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.140.3.631 · Cited by 256
C-reactive protein and the acute phase response.
Gewurz, H., Mold, C., Siegel, J. N., & Fiedel, B. A. (1982) · PubMed · Cited by 243
Immune Complexes, Complement, and Anti-DNA in Exacerbations of Systemic Lupus Erythematosus (SLE)
LLOYD, W., & SCHUR, P. H. (1981) · Medicine · doi:10.1097/00005792-198105000-00004 · Cited by 242
Stern, M., Savill, J., & Haslett, C. (1996) · Europe PMC (PubMed Central) · Cited by 239
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers
Volanakis, J. E., & Wirtz, K. W. A. (1979) · Nature · doi:10.1038/281155a0 · Cited by 236
Apoptosis and functional fas antigen in rheumatoid arthritis synoviocytes
Nakajima, T., Aono, H., Hasunuma, T., Yamamoto, K., Shirai, T., Hirohata, K., & Nishioka, K. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380405 · Cited by 231
Regulation of the Complement Membrane Attack Pathway
Morgan, B. P. (1999) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v19.i3.10 · Cited by 222
De Beer, F. C., Fagan, E., Hughes, G. R. V., Mallya, R. K., Lanham, J. G., & Pepys, M. B. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90321-x · Cited by 212
CD14-dependent clearance of apoptotic cells: relevance to the immune system
Gregory, C. D. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00047-3 · Cited by 187
A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells
Hack, C. E., Wolbink, G.-J., Schalkwijk, C., Speijer, H., Hermens, W. T., & van den Bosch, H. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01002-5 · Cited by 184
Robey, F. A., Jones, K. D., Tanaka, T., & Liu, T. Y. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39873-3 · Cited by 183
PHYLOGENETIC ASPECTS OF C‐REACTIVE PROTEIN AND RELATED PROTEINS*
Baltz, M. L., De Beer, F. C., Feinstein, A., Munn, E. A., Milstein, C. P., Fletcher, T. C., March, J. F., Taylor, J., Bruton, C., Clamp, J. R., et al. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22125.x · Cited by 172
STUDIES OF ACUTE PHASE PROTEIN
Kushner, I., & Kaplan, M. H. (1961) · The Journal of Experimental Medicine · doi:10.1084/jem.114.6.961 · Cited by 163
Integrins as promiscuous signal transduction devices
Petty, H. R., & Todd, R. F. (1996) · Immunology Today · doi:10.1016/0167-5699(96)30013-3 · Cited by 158
Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages.
Yamamoto, K., & Johnston, R. B. (1984) · The Journal of Experimental Medicine · doi:10.1084/jem.159.2.405 · Cited by 154
The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations
Vaishnaw, A. K., Orlinick, J. R., Chu, J., Krammer, P. H., Chao, M. V., & Elkon, K. B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5121 · Cited by 154
Self-citationAderem, A. A., Wright, S. D., Silverstein, S. C., & Cohn, Z. A. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.161.3.617 · Cited by 128
C-reactive protein reacts with the U1 small nuclear ribonucleoprotein.
Clos, T. W. D. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2553 · Cited by 124
Jiang, H., Siegel, J. N., & Gewurz, H. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.7.2324 · Cited by 113
The interaction of C-reactive protein and serum amyloid P component with nuclear antigens
Clos, T. W. D. (1996) · Molecular Biology Reports · doi:10.1007/bf00351177 · Cited by 103
Szalai, A. J., Agrawal, A. C., Greenhough, T. J., & Volanakis, J. E. (1997) · Immunologic Research · doi:10.1007/bf02786357 · Cited by 97
The variable morphological coexistence of apoptosis and necrosis in human myocardial infarction
James, T. N. (1998) · Coronary Artery Disease · doi:10.1097/00019501-199809050-00007 · Cited by 70
Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis.
Berman, S., Gewurz, H., & Mold, C. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.4.1354 · Cited by 65
Mold, C., & Gewurz, H. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.5.2089 · Cited by 44
A novel flow cytometric method for quantifying phagocytosis of apoptotic cells
Hess, K. L., Babcock, G. F., Askew, D. S., & Cook‐Mills, J. M. (1997) · Cytometry · Cited by 39
Vik, D. P., Muñoz‐Cánoves, P., Chaplin, D., & Tack, B. F. (1990) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-74977-3_8 · Cited by 15
Regulation of complement by direct binding of factor H to C-reactive protein
Mold, C., Stein, M., & Clos, T. W. D. (1998) · Molecular Immunology · doi:10.1016/s0161-5890(98)90593-4 · Cited by 5
Cited by
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
“Early stage effectors are preferentially used because the modified apoptotic cell surface acquires CRP and C1q together with f”
BackgroundC-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Role of C-Reactive Protein at Sites of Inflammation and Infection
Sproston, N. R., & Ashworth, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00754 · Cited by 3,029
Black, S., Kushner, I., & Samols, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400025200 · Cited by 1,844
Metadata
- Authors
- Gershov, D., Kim, S., Brot, N., & Elkon, K. B.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2000-11-06
- Volume
- 192
- Issue
- 9
- Pages
- 1353-1364
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2148045758
- Cited by
- 695
- References
- 59
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.